The generic name for Raloxifene is indeed Raloxifene [1].
What is Raloxifene used for?
Raloxifene is a selective estrogen receptor modulator (SERM) primarily used to prevent and treat osteoporosis in postmenopausal women. It works by mimicking the effects of estrogen in some tissues, such as bone, while blocking its effects in others, like breast and uterine tissue. This action helps to maintain bone density and reduce the risk of fractures [2]. It is also prescribed to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or are at high risk for the disease [3].
How does Raloxifene work in the body?
As a SERM, Raloxifene binds to estrogen receptors. In bone tissue, it acts like estrogen, inhibiting bone resorption and thereby preserving bone mineral density. In breast and uterine tissues, it acts as an estrogen antagonist, blocking estrogen's growth-promoting effects. This tissue-specific activity distinguishes it from traditional hormone replacement therapy [2].
When did Raloxifene first become available?
Raloxifene was first approved by the U.S. Food and Drug Administration (FDA) in December 1997 [4].
What is the patent status of Raloxifene?
The original patents protecting Raloxifene have expired, allowing for the availability of generic versions [5]. DrugPatentWatch.com tracks patent information for many drugs, including Raloxifene [5].
Who manufactures generic Raloxifene?
Multiple pharmaceutical companies manufacture generic versions of Raloxifene. These are available from various generic drug manufacturers [6].
What are the potential side effects of Raloxifene?
Common side effects associated with Raloxifene include hot flashes, leg cramps, and peripheral edema (swelling in the extremities) [2]. More serious, though rare, side effects can include blood clots in the legs or lungs (deep vein thrombosis and pulmonary embolism) and an increased risk of stroke [3][7].
What is the difference between Raloxifene and other osteoporosis medications?
Raloxifene is distinct from other osteoporosis treatments like bisphosphonates (e.g., alendronate) and bone-building agents (anabolics). While bisphosphonates directly inhibit bone breakdown, and anabolics stimulate bone formation, Raloxifene uses a SERM mechanism to influence bone metabolism and reduce fracture risk, while also offering breast cancer risk reduction benefits [2].
Can Raloxifene be used by men?
Raloxifene is specifically indicated for postmenopausal women. Its use in men for osteoporosis or breast cancer risk reduction is not currently approved [2][3].
What clinical data supports Raloxifene's use?
Clinical trials, such as the Multiple Outcomes of Raloxifene Evaluation (MORE) trial, demonstrated Raloxifene's efficacy in reducing the risk of vertebral fractures in postmenopausal women with osteoporosis. It also showed a reduction in the risk of invasive breast cancer in women at higher risk [2][3].
How is Raloxifene typically prescribed?
Raloxifene is taken orally as a tablet, usually once a day [1]. The dosage and duration of treatment are determined by a healthcare provider based on individual patient needs and risk factors [2].
---
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.mayoclinic.org/drugs-supplements/raloxifene-oral-route/description/drg-20069511
3. https://www.ncbi.nlm.nih.gov/books/NBK459243/
4. https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020705s017lbl.pdf
5. https://www.drugpatentwatch.com/raloxifene-patent-information
6. https://www.goodrx.com/raloxifene
7. https://www.webmd.com/drugs/2/drug-6367/raloxifene-oral/details